cholecystokinin 9 has been researched along with n-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide in 2 studies
| Studies (cholecystokinin 9) | Trials (cholecystokinin 9) | Recent Studies (post-2010) (cholecystokinin 9) | Studies (n-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide) | Trials (n-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide) | Recent Studies (post-2010) (n-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide) |
|---|---|---|---|---|---|
| 23 | 1 | 3 | 21 | 1 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buyse, J; Cokelaere, M; De Cuyper, M; León-Tamariz, F; Pottel, H; Van Boven, M; Verbaeys, I | 1 |
| Cokelaere, M; Decuypere, E; León-Tamariz, F; Pottel, H; Swennen, Q; Verbaeys, I | 1 |
2 other study(ies) available for cholecystokinin 9 and n-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide
| Article | Year |
|---|---|
PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
Topics: Animals; Anorexia; Appetite Depressants; Aspartic Acid; Blood-Brain Barrier; Cholecystokinin; Delayed-Action Preparations; Devazepide; Dose-Response Relationship, Drug; Eating; Injections, Intraperitoneal; Male; Naphthalenesulfonates; Peptide Fragments; Polyethylene Glycols; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Satiation | 2007 |
PEGylated cholecystokinin is more potent in inducing anorexia than conditioned taste aversion in rats.
Topics: Animals; Anorexia; Aspartic Acid; Avoidance Learning; Cholecystokinin; Devazepide; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Naphthalenesulfonates; Peptide Fragments; Polyethylene Glycols; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Saccharin; Satiety Response; Taste | 2008 |